Glenn Frank Short's most recent trade in ATAI Life Sciences N.V. was a trade of 13,161 Common Shares done at an average price of $1.3 . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ATAI Life Sciences NV | Glenn Frank Short | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.35 per share. | 21 Mar 2025 | 13,161 | 42,333 | - | 1.3 | 17,767 | Common Shares |
| ATAI Life Sciences NV | Glenn Frank Short | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 32,500 | 55,494 | - | - | Common Shares | |
| ATAI Life Sciences NV | Glenn Frank Short | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 32,500 | 0 | - | - | Restricted Stock Units | |
| ATAI Life Sciences NV | Glenn Frank Short | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 757,915 | 757,915 | - | - | Stock Option |